搜索临床试验以:I 131
总计495138个结果
-
University of WuerzburgDeutsche Krebshilfe e.V., Bonn (Germany)招聘中
-
GlaxoSmithKline完全的
-
Stealth BioTherapeutics Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.终止
-
University of NebraskaNational Cancer Institute (NCI); Coulter Pharmaceutical, Inc.终止
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company招聘中
-
Changhai HospitalGuilin Medical University, China; Shanxi Province Cancer Hospital; First People's Hospital of... 和其他合作者未知
-
Sidney Kimmel Comprehensive Cancer Center at Johns...GlaxoSmithKline完全的
-
Stealth BioTherapeutics Inc.完全的
-
Weill Medical College of Cornell UniversityIsoRay Medical, Inc.撤销
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)终止复发性霍奇金淋巴瘤 | 难治性霍奇金淋巴瘤 | 难治性 B 细胞非霍奇金淋巴瘤 | 难治性 T 细胞非霍奇金淋巴瘤 | 复发性 B 细胞非霍奇金淋巴瘤 | 复发性 T 细胞非霍奇金淋巴瘤美国
-
Memorial Sloan Kettering Cancer CenterGT Medical Technologies, Inc.招聘中
-
University of Michigan Rogel Cancer CenterGlaxoSmithKline主动,不招人
-
Stealth BioTherapeutics Inc.完全的
-
Stealth BioTherapeutics Inc.终止
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Rush University Medical CenterGlaxoSmithKline; Millennium Pharmaceuticals, Inc.终止
-
University of WashingtonNational Cancer Institute (NCI); GlaxoSmithKline; National Comprehensive Cancer Network完全的复发性甲状腺癌 | IVA 期滤泡性甲状腺癌 | IVA 期甲状腺乳头状癌 | IVB 期滤泡性甲状腺癌 | IVB 期乳头状甲状腺癌 | IVC 期滤泡性甲状腺癌 | IVC 期甲状腺乳头状癌美国
-
GlaxoSmithKline撤销淋巴瘤,滤泡性 | 淋巴瘤,非霍奇金 | 淋巴瘤,小裂细胞,滤泡 | 淋巴瘤,大细胞,滤泡美国
-
Motus Therapeutics, Inc.Michael J. Fox Foundation for Parkinson's Research终止
-
Jubilant DraxImage Inc.招聘中
-
National Cancer Institute (NCI)主动,不招人复发性甲状腺癌 | 低分化甲状腺癌 | 难治性甲状腺癌 | IV 期甲状腺滤泡性癌 AJCC v7 | IV 期甲状腺乳头状癌 AJCC v7 | IVA 期甲状腺滤泡性癌 AJCC v7 | IVA 期甲状腺乳头状癌 AJCC v7 | IVB 期甲状腺滤泡性癌 AJCC v7 | IVB 期甲状腺乳头状癌 AJCC v7 | IVC 期甲状腺滤泡性癌 AJCC v7 | IVC 期甲状腺乳头状癌 AJCC v7 | 转移性甲状腺癌美国
-
University of CincinnatiIsoRay Medical, Inc.主动,不招人
-
Stealth BioTherapeutics Inc.完全的
-
Children's Hospital Medical Center, Cincinnati不再可用
-
Corixa Corporation未知
-
Corixa CorporationGlaxoSmithKline未知